Gingival crevicular fluid IL-6, tPA, PAI-2, albumin levels following initial periodontal treatment in chronic periodontitis patients with or without type 2 diabetes


KARDESLER L., BUDUNELI N., ÇETİNKALP Ş. , Lappin D., Kinane D. F.

INFLAMMATION RESEARCH, vol.60, no.2, pp.143-151, 2011 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 60 Issue: 2
  • Publication Date: 2011
  • Doi Number: 10.1007/s00011-010-0248-7
  • Title of Journal : INFLAMMATION RESEARCH
  • Page Numbers: pp.143-151
  • Keywords: Diabetes mellitus, ELISA, Gingival crevicular fluid, IL-6, Plasminogen activators, Periodontal disease, GLYCEMIC CONTROL, BONE LOSS, MELLITUS, THERAPY, INTERLEUKIN-1-BETA, DISEASE

Abstract

To evaluate initial periodontal treatment effects on gingival crevicular fluid (GCF) interleukin-6 (IL-6), tissue-type plasminogen activator (tPA), plasminogen activator inhibitor-2 (PAI-2), albumin levels in type 2 diabetic patients.